Open AccessContinuous focus on COVID‐19 epidemic: Changes in China’s clinical guidance
Author(s) -
Wang QianChen,
Wang ZhenYu
Publication year - 2021
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/ijcp.13869
Subject(s) - medicine , covid-19 , china , epidemiology , disease , outbreak , pandemic , etiology , medline , intensive care medicine , pathology , infectious disease (medical specialty) , geography , archaeology , political science , law
Backgrounds The epidemic of coronavirus disease 2019 (COVID‐19) is spreading across the world. As the first country who suffered from the outbreak, China has been taking strict and effective measures to contain the epidemic and treat the disease under the instruction of updating guidance. Aims To compare the changes and updates in China's clinical guidance for COVID‐19. Methods We explored China's experience in dealing with the epidemic by l ongitudinal comparison of China's clinical guidance for COVID‐19. Results As of March 4, there are 7 editions of the guidance. With the increasing understanding of COVID‐19, changes have been made in aetiology, epidemiology, pathology, clinical features, diagnostic criteria, clinical classification, and treatment. Conclusions We have made a summary of the changes and updates in China's clinical guidance for COVID‐19, which mirrors the deepening understanding of the disease over the course of fighting it, hoping to help clinicians worldwide.